Navigation Links
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1
Date:7/25/2014

#160;are registered service marks of Arena Pharmaceuticals, Inc. BELVIQ® is a registered trademark of Arena Pharmaceuticals GmbH.

Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about embracing the challenge of improving health; seeking to bring innovative medicines to patients; and Arena's focus, plans, goals, strategy, expectations, research and development programs, and ability to discover and develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: risks related to commercializing drugs, including regulatory, manufacturing, supply and marketing issues and the availability and use of BELVIQ; cash and revenues generated from BELVIQ, including the impact of competition; Arena's revenues will be based in part on estimates, judgment and accounting policies, and incorrect estimates or disagreement regarding estimates or accounting policies may result in changes to Arena's guidance or previously reported results; the timing and outcome of regulatory review is uncertain, and BELVIQ may not be approved for marketing when expected or ever in combination with another drug, for another indication or using a different formulation or in any other territory for any indication; regulatory decisions in one territory may impact other regulatory decisions and Arena's business prospects; government and commercial reimbursement and pricing decisions; risks related to relying on collaborative arrangements; the timing and receipt of payments and fees, if any, from collaborators; the entry into or modification or termina
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena
2. Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
3. Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
4. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
5. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
8. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
9. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
10. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
11. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Pa. , July 1, 2015 ... fully integrated specialty pharmaceutical company focused on developing, ... that Bob Radie , president and chief ... conferences this summer. He will provide an update ... (ketorolac tromethamine) Nasal Spray, approved product ...
(Date:7/1/2015)... July 1, 2015 New exchange plan enrollees ... 2015 compared to the same time a year ago, ... (NASDAQ: ESRX ) Exchange Pulse™ report, released today. ... 2014, the number of new exchange plan enrollees who ... in the first quarter of 2015. However, when evaluating ...
(Date:7/1/2015)... The Haselmeier Group has decided ... Gert Weber has been nominated by the Board ... Executive Officer (CEO) of the Haselmeier Group. This ... Mr. Weber brings more than 20 years of experience ... various executive management positions, the last being Managing Director ...
Breaking Medicine Technology:Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity ... shine Saturday, July 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield ... pony rides, a petting zoo, an Elvis impersonator, a silent auction and concessions. , ...
(Date:7/1/2015)... ... 01, 2015 , ... As if mood swings, cramps and child labor weren’t ... women: leg pain. Northeast Houston Vein Center is offering tips on the treatment options ... disease, is underdiagnosed and often overlooked. Many women experience the tiredness, achiness, restless legs, ...
(Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning social policy often ... Professor in FIU’s School of International and Public Affairs. , The ... in the National Survey on Drug Use and Health, which is a nationally ...
(Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. is a proud ... paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the Health Care Transformation ... http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is a group of ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... solution provider of IBM software products, announced today that it has received trademark ... the integration, display and detailed analysis of data from multiple sources providing an ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4
... juice, but not all experts agree with findings , , TUESDAY, ... fruit juices apparently don,t tend to be overweight, and they ... the beverages, a new study finds. , "We found juice ... A. Nicklas, a professor of pediatrics at Baylor College of ...
... June 3 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. ... "CSY"), a manufacturer,marketer and distributor of pharmaceutical, medicinal ... five of its products have,received production permit approvals ... China Sky One Medical began to develop products ...
... have long wrestled with how to aid those who ... to inject an artificial gel that can imitate cartilage,s ... But that solution is temporary, requiring follow-up injections. , ... a way to regenerate cartilage naturally by creating a ...
... David Hayes-Bautista and Linda Squires-Grohe Awarded $25,000 Each for ... ... Professions, SAN FRANCISCO, June 3 Three ... Health,Professions Diversity by The California Wellness Foundation (TCWF). Juanita,Barrena has played ...
... CHAPEL HILL, N.C., June 3 Market competition ... of the most qualified,clinical investigators. Field research shows ... 60-70% of the clinical trial,invitations that they receive ... are seeking better ways to manage the art,and ...
... 3 Burgess(TM) will be,a sponsor of ... most prominent,gatherings, held June 18th-20th in San ... and educational products,and services., A Burgess(TM) ... Health care: What are the New Data ...
Cached Medicine News:Health News:Fruit Juice May Be Healthy for Kids: Study 2Health News:Fruit Juice May Be Healthy for Kids: Study 3Health News:China Sky One Medical, Inc. Receives SFDA Approval for Five Patches 2Health News:China Sky One Medical, Inc. Receives SFDA Approval for Five Patches 3Health News:Brown researchers work toward ending cartilage loss 2Health News:Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award 2Health News:Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award 3Health News:Best Practice Toolkit Supports Recruitment of Top Clinical Investigators 2
... Simplex™ P with Tobramycin ... Bone Cement formula, with the ... By maintaining the original formula, ... performance characteristics of Simplex™ P ...
... Flow Analyzer is a fast, clinically proven ... of low and normal-tension glaucoma., ,The Ocular ... clinically proven measurement that improves detection of ... management of glaucoma, and detection of other ...
... Flexible Dosposable Easy Insertion/Removal ... (CSS) provides absolutely reliable support to ... thereby permitting routine phacoemulsification regardless of ... easy (similar to disposable iris retractors), ...
The collagen intracanicular plugs have a smooth proprietary finish that simplifies insertion of the plug. Collagen plugs are ideal for short term, diagnostic and post-surgical occlusion. Plugs are 2m...
Medicine Products: